Anti-topoisomerase-I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus

Anti-nucleosome antibodies and systemic lupus erythematosus

Annexin A5 polymorphism and anti-annexin A5 antibodies in systemic lupus erythematosus

Antichromatin Antibodies In Systemic LupusErythematosus

Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients : Relation to disease activity and manifestations

Antibodies to cyclic citrullinated peptide in a groupof patients with rheumatoid and SLE arthritis

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients and its relation to disease activity

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

Distribution of macrovascular disease in upper extremities of scleroderma patients

Recent advances in understanding and management ofthe antiphospholipid syndrome